Vaginal Atrophy Clinical Trials

A listing of Vaginal Atrophy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 365 clinical trials
featured
Accelerated Genital Tract Aging in HIV: Estradiol Clinical Trial

of vaginal atrophy in menopausal women living with HIV. 

  • 37 views
  • 03 Mar, 2021
  • 1 location
featured
Vaginal Atrophy / Vaginal Dryness

Vaginal Atrophy / Vaginal Dryness

  • 1134 views
  • 23 Nov, 2020
  • 1 location
featured
A study for patients with moderate vaginal dryness due to menopause.

A study for patients with moderate vaginal dryness due to menopause.

  • 336 views
  • 23 Nov, 2020
  • 1 location
featured
Vaginal dryness

Vaginal dryness

  • 813 views
  • 25 Mar, 2021
  • 1 location
A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer

This study is designed to determine the efficacy and safety of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple negative breast cancer

trastuzumab
HER2
paclitaxel
cancer
triple negative breast cancer
  • 400 views
  • 29 Aug, 2021
  • 65 locations
Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico

Primary Objective: To describe the antibody titers to the antigens (meningococcal serogroups A, C, Y, and present in MenACYW conjugate vaccine or Menveo measured by serum bactericidal assay using human complement (hSBA), for Groups 1 and 2 when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in …

  • 7 views
  • 11 Apr, 2021
  • 11 locations
Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

This multicenter, randomized, double-blind study will evaluate the efficacy and safety of Toripalimab (JS001) combined with nab-paclitaxel compared with placebo combined with nab-paclitaxel for first/second line treatment of metastatic or recurrent triple-negative breast cancer (TNBC).

HER2
triple-negative breast cancer
taxane
growth factor
paclitaxel
  • 28 views
  • 24 Jan, 2021
  • 79 locations
A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

Study MO39874 is an open-label, phase IIIb, single arm, multicenter study conducted in participants with unresectable locally advanced or metastatic PD-L1-positive Triple-Negative Breast Cancer (TNBC) who have not received chemotherapy for their unresectable locally advanced or metastatic disease.

programmed cell death 1 ligand 1
breast adenocarcinoma
serum pregnancy test
pd-l1
HER2
  • 147 views
  • 23 Sep, 2021
  • 164 locations
Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

The purpose of this study is to compare the efficacy of olaparib (MK-7339) plus pembrolizumab (MK-3475) with chemotherapy plus pembrolizumab after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The primary hypotheses are: Olaparib plus pembrolizumab prolongs progression-free survival (PFS) compared with chemotherapy plus pembrolizumab. Olaparib …

mk-3475
anthracyclines
taxane
cancer
triple negative breast cancer
  • 241 views
  • 23 Sep, 2021
  • 134 locations
Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers

The primary objective of this study is to describe the safety profile of MenACYW conjugate vaccine and MENVEO when administered concomitantly with routine pediatric vaccines in healthy infants and toddlers

  • 944 views
  • 26 Jan, 2021
  • 76 locations